PDE9A
High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A
Also known as: PDE9A_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- O76083
- Gene
- PDE9A
- Ensembl
- ENSG00000160191
- Chromosome
- 21
- Canonical length
- 593 aa
- Protein class
- Enzymes, Metabolic proteins, Predicted intracellular proteins
- Subcellular location
- Nucleoplasm,Plasma membrane,Cytosol
- Quaternary structure
- Homodimer
OverviewNCBI Gene
The protein encoded by this gene catalyzes the hydrolysis of cAMP and cGMP to their corresponding monophosphates. The encoded protein plays a role in signal transduction by regulating the intracellular concentration of these cyclic nucleotides. Multiple transcript variants encoding several different isoforms have been found for this gene. [provided by RefSeq, Jul 2008]
Canonical amino-acid sequenceUniProt
593 residues, UniProt reviewed canonical sequence.
>O76083|PDE9A
1 MGSGSSSYRP KAIYLDIDGR IQKVIFSKYC NSSDIMDLFC IATGLPRNTT ISLLTTDDAM
61 VSIDPTMPAN SERTPYKVRP VAIKQLSAGV EDKRTTSRGQ SAERPLRDRR VVGLEQPRRE
121 GAFESGQVEP RPREPQGCYQ EGQRIPPERE ELIQSVLAQV AEQFSRAFKI NELKAEVANH
181 LAVLEKRVEL EGLKVVEIEK CKSDIKKMRE ELAARSSRTN CPCKYSFLDN HKKLTPRRDV
241 PTYPKYLLSP ETIEALRKPT FDVWLWEPNE MLSCLEHMYH DLGLVRDFSI NPVTLRRWLF
301 CVHDNYRNNP FHNFRHCFCV AQMMYSMVWL CSLQEKFSQT DILILMTAAI CHDLDHPGYN
361 NTYQINARTE LAVRYNDISP LENHHCAVAF QILAEPECNI FSNIPPDGFK QIRQGMITLI
421 LATDMARHAE IMDSFKEKME NFDYSNEEHM TLLKMILIKC CDISNEVRPM EVAEPWVDCL
481 LEEYFMQSDR EKSEGLPVAP FMDRDKVTKA TAQIGFIKFV LIPMFETVTK LFPMVEEIML
541 QPLWESRDRY EELKRIDDAM KELQKKTDSL TSGATEKSRE RSRDVKNSEG DCALocalizationUniProt · AlphaFold · HPA
Whether an antibody against PDE9A can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Cell surface
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.36
- Highest tissue expression
- 70 nTPM
Expression across tissuesHPA
Tissue
- colon: 70 nTPM
- small intestine: 45 nTPM
- prostate: 37 nTPM
- kidney: 27 nTPM
- basal ganglia: 24 nTPM
- urinary bladder: 21 nTPM
Single-cell type
- enterocytes: 514 nCPM
- prostatic glandular cells: 323 nCPM
- oocytes: 216 nCPM
- retinal horizontal cells: 202 nCPM
- loop of henle epithelial cells: 198 nCPM
- somatotrophs: 191 nCPM
Immune cell
- naive CD4 T-cell: 3.1 nTPM
- T-reg: 1 nTPM
- memory CD4 T-cell: 0.9 nTPM
- NK-cell: 0.9 nTPM
- naive CD8 T-cell: 0.6 nTPM
- neutrophil: 0.4 nTPM
Brain region
- thalamus: 19 nTPM
- basal ganglia: 18 nTPM
- midbrain: 17 nTPM
- cerebellum: 16 nTPM
- pons: 14 nTPM
- hypothalamus: 13 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.49
- gnomAD pLI
- 0
- gnomAD missense Z
- 1.09
- DepMap mean gene effect
- 0.08
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 5% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- cGMP catabolic process
- cGMP metabolic process
- negative regulation of cAMP/PKA signal transduction
- negative regulation of neural precursor cell proliferation
- positive regulation of cardiac muscle hypertrophy
- positive regulation of long-term synaptic potentiation
- signal transduction
Molecular functions
- 3',5'-cyclic-AMP phosphodiesterase activity
- 3',5'-cyclic-GMP phosphodiesterase activity
- 3',5'-cyclic-nucleotide phosphodiesterase activity
- identical protein binding
- metal ion binding
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of PDE9A in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads PDE9A as an antibody target. Whether an autoantibody or antibody against PDE9A could matter depends on whether native PDE9A is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
PDE9A is annotated at the cell surface, where native PDE9A is exposed to circulating antibodies and is a prime autoantibody target that could block, deplete, or overstimulate it.
Annotation status
The present source text does not explicitly label PDE9A as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...